> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# New OND Research Web Page
- URL: https://www.fdaweb.com/new-ond-research-web-page/
- Published: 2022-09-13T12:00:00.000Z
- Updated: 2026-09-14T17:59:04.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5152722

FDA says it has launched a new Web page to highlight the most recent research activities of CDER’s Office of New Drugs (OND). The [Web page](https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-new-drugs-regulatory-science-research?ref=fdaweb.com) says OND created its research program in 2019 to foster regulatory science research (RSR). “OND-led RSR projects are designed to address knowledge gaps identified during regulatory review of investigational or new drug applications,” it says.

The initial postings to the page cover Extramural Research, Intramural Research, Targeted Funding Opportunities Open to External Partners, Other OND RSR resources, Other CDER RSR Resources, and Contact Information.